دورية أكاديمية

Development and feasibility of a telemedicine tool for patients with recurrent urinary tract infection: myRUTIcoach.

التفاصيل البيبلوغرافية
العنوان: Development and feasibility of a telemedicine tool for patients with recurrent urinary tract infection: myRUTIcoach.
المؤلفون: Pat JJ; Department of General Practice and elderly Care Medicine, University of Groningen, University Medical Centre, Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. j.j.pat@umcg.nl.; Department of Urology, ISALA Clinics, Dokter van Heesweg 2, 8025 AB, Zwolle, The Netherlands. j.j.pat@umcg.nl., Pape CCET; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, The Netherlands., Steffens MG; Department of Urology, ISALA Clinics, Dokter van Heesweg 2, 8025 AB, Zwolle, The Netherlands., Witte LPW; Department of Urology, ISALA Clinics, Dokter van Heesweg 2, 8025 AB, Zwolle, The Netherlands., Blanker MH; Department of General Practice and elderly Care Medicine, University of Groningen, University Medical Centre, Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
المصدر: International urogynecology journal [Int Urogynecol J] 2023 Nov; Vol. 34 (11), pp. 2817-2825. Date of Electronic Publication: 2023 Sep 27.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: England NLM ID: 101567041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-3023 (Electronic) Linking ISSN: 09373462 NLM ISO Abbreviation: Int Urogynecol J Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Springer
مواضيع طبية MeSH: Urinary Tract Infections*/prevention & control , Telemedicine*, Humans ; Female ; Feasibility Studies ; Patient Compliance
مستخلص: Introduction and Hypothesis: Patients with recurrent urinary tract infection (rUTI) have limited knowledge of preventive strategies to lower the risk of UTI. We aimed to develop and test the feasibility of an eHealth system for women with rUTI, named myRUTIcoach, and explored the facilitators and barriers related to its adoption.
Methods: We developed myRUTIcoach in a structured iterative process and tested its feasibility among 25 women with rUTI over 2 months. Subsequent questionnaires covered satisfaction, accessibility, and experiences with myRUTIcoach. A random selection of participants and relevant stakeholders took part in semi-structured interviews to explore adoption. Data were analyzed and elaborated using inductive and deductive approaches using the Non-adoption, Abandonment, Spread, Scale-up, and Sustainability (NASSS) framework.
Results: MyRUTIcoach was not only widely accepted but also facilitated communication with health care professionals (HCPs) and contributed to greater knowledge of rUTI. Women graded the system a mean of 8.0 (±0.6) out of 10, with 89% stating that they would recommend it to others. Patients indicated that self-management skills were the major facilitators and barriers related to adoption, whereas HCPs stated that the disconnect between myRUTIcoach and electronic health care records (EHRs) was the major barrier.
Conclusions: This research describes the development and testing of myRUTIcoach for women with rUTI. Patients and HCPs reported high satisfaction and compliance with myRUTIcoach. However, adoption by the intended users is complex and influenced by all examined domains of the NASSS framework. We have already improved linkage to EHRs, but further optimization to meet patient needs may improve the effectiveness of this self-management tool for rUTI.
(© 2023. The Author(s).)
References: Prim Health Care Res Dev. 2021 Apr 05;22:e11. (PMID: 33818360)
Am J Epidemiol. 2000 Jun 15;151(12):1194-205. (PMID: 10905532)
J Telemed Telecare. 2013 Jul;19(5):242-8. (PMID: 24163233)
Lancet. 2017 Sep 2;390(10098):959-968. (PMID: 28716313)
J Med Internet Res. 2017 Nov 01;19(11):e367. (PMID: 29092808)
BMC Health Serv Res. 2015 Oct 02;15:447. (PMID: 26431695)
Eur Urol Focus. 2021 Jan;7(1):198-204. (PMID: 32088140)
Urology. 2021 May;151:8-12. (PMID: 32673677)
Int Urogynecol J. 2022 May;33(5):1059-1070. (PMID: 35142870)
BMC Urol. 2020 Dec 2;20(1):190. (PMID: 33267816)
JMIR Res Protoc. 2020 May 13;9(5):e16861. (PMID: 32401224)
BMC Public Health. 2021 Aug 17;21(1):1556. (PMID: 34399716)
فهرسة مساهمة: Keywords: NASSS; Qualitative research; RUTI; eHealth
تواريخ الأحداث: Date Created: 20230927 Date Completed: 20231128 Latest Revision: 20231130
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10682280
DOI: 10.1007/s00192-023-05634-x
PMID: 37755525
قاعدة البيانات: MEDLINE
الوصف
تدمد:1433-3023
DOI:10.1007/s00192-023-05634-x